{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:39:44Z","timestamp":1785465584846,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the shandong natural science foundation project","award":["ZR2022MH276"],"award-info":[{"award-number":["ZR2022MH276"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06249-9","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:50:08Z","timestamp":1772628608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Extended-course transcutaneous tibial nerve stimulation for pediatric overactive bladder: a 6-Month prospective single-arm study"],"prefix":"10.1007","volume":"44","author":[{"given":"Fangzheng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"6","key":"6249_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2165\/00148581-200709060-00005","volume":"9","author":"I Franco","year":"2007","unstructured":"Franco I (2007) Pediatric overactive bladder syndrome: pathophysiology and management. Paediatr Drugs 9(6):379\u2013390","journal-title":"Paediatr Drugs"},{"issue":"8","key":"6249_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1056\/NEJMra032662","volume":"350","author":"JG Ouslander","year":"2004","unstructured":"Ouslander JG (2004) Management of overactive bladder. N Engl J Med 350(8):786\u2013799","journal-title":"N Engl J Med"},{"issue":"11","key":"6249_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.purol.2015.04.005","volume":"25","author":"O Bouali","year":"2015","unstructured":"Bouali O et al (2015) [Tibial nerve transcutaneous stimulation for refractory idiopathic overactive bladder in children and adolescents]. Prog Urol 25(11):665\u2013672","journal-title":"Prog Urol"},{"key":"6249_CR4","doi-asserted-by":"crossref","unstructured":"Franco I (2007) Overactive bladder in children. Part 1: Pathophysiology. J Urol, 178(3 Pt 1): pp. 761-8; discussion 768","DOI":"10.1016\/j.juro.2007.05.014"},{"issue":"4","key":"6249_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/nau.22751","volume":"35","author":"PF Austin","year":"2016","unstructured":"Austin PF et al (2016) The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the international children\u2019s continence society. Neurourol Urodyn 35(4):471\u2013481","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"6249_CR6","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1590\/s1677-5538.ibju.2021.0177","volume":"47","author":"R Gondim","year":"2021","unstructured":"Gondim R et al (2021) Evaluation of autonomic function in children and adolescents with overactive bladder. Int Braz J Urol 47(6):1178\u20131188","journal-title":"Int Braz J Urol"},{"issue":"9","key":"6249_CR7","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nrurol.2016.152","volume":"13","author":"I Franco","year":"2016","unstructured":"Franco I (2016) Overactive bladder in children. Nat Rev Urol 13(9):520\u2013532","journal-title":"Nat Rev Urol"},{"issue":"6","key":"6249_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00192-016-3225-z","volume":"28","author":"S Rachaneni","year":"2017","unstructured":"Rachaneni S, Latthe P (2017) Effectiveness of BTX-A and neuromodulation in treating OAB with or without detrusor overactivity: a systematic review. Int Urogynecol J 28(6):805\u2013816","journal-title":"Int Urogynecol J"},{"issue":"8","key":"6249_CR9","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neurom.2022.04.034","volume":"25","author":"AM Sayner","year":"2022","unstructured":"Sayner AM et al (2022) Transcutaneous tibial nerve stimulation in the management of overactive bladder: A scoping review. Neuromodulation 25(8):1086\u20131096","journal-title":"Neuromodulation"},{"issue":"1","key":"6249_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13063-021-05117-8","volume":"22","author":"L Ghijselings","year":"2021","unstructured":"Ghijselings L et al (2021) Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus Sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial. Trials 22(1):247","journal-title":"Trials"},{"issue":"5","key":"6249_CR11","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1097\/JS9.0000000000000338","volume":"109","author":"Y Chen","year":"2023","unstructured":"Chen Y et al (2023) The effectiveness and safety of oral medications, OnabotulinumtoxinA (three doses) and transcutaneous tibial nerve stimulation as Non or minimally invasive treatment for the management of neurogenic detrusor overactivity in adults: a systematic review and network meta-analysis. Int J Surg 109(5):1430\u20131438","journal-title":"Int J Surg"},{"issue":"6","key":"6249_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/bju.16330","volume":"133","author":"L Liao","year":"2024","unstructured":"Liao L et al (2024) Efficacy and safety of tibial nerve stimulation using a wearable device for overactive bladder. BJU Int 133(6):760\u2013769","journal-title":"BJU Int"},{"issue":"6","key":"6249_CR13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.euf.2024.05.013","volume":"10","author":"JN Cornu","year":"2024","unstructured":"Cornu JN et al (2024) New TENSI+ device for transcutaneous posterior tibial nerve stimulation: A Prospective, Multicentre, Post-market clinical study. Eur Urol Focus 10(6):983\u2013990","journal-title":"Eur Urol Focus"},{"issue":"1","key":"6249_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/nau.22911","volume":"36","author":"SJ Chang","year":"2017","unstructured":"Chang SJ et al (2017) Treatment of daytime urinary incontinence: A standardization document from the international children\u2019s continence society. Neurourol Urodyn 36(1):43\u201350","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"6249_CR15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00787-017-1051-6","volume":"27","author":"SK Sch\u00e4fer","year":"2018","unstructured":"Sch\u00e4fer SK et al (2018) Standard urotherapy as first-line intervention for daytime incontinence: a meta-analysis. Eur Child Adolesc Psychiatry 27(8):949\u2013964","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1","key":"6249_CR16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s13063-022-06600-6","volume":"23","author":"LL de Wall","year":"2022","unstructured":"de Wall LL et al (2022) Study protocol for a parallel-group randomized controlled multi-center trial evaluating the additional effect of continuous ultrasound bladder monitoring in urotherapy for children with functional daytime urinary incontinence (SENS-U trial). Trials 23(1):648","journal-title":"Trials"},{"issue":"1","key":"6249_CR17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41598-020-79974-9","volume":"11","author":"F Sawaqed","year":"2021","unstructured":"Sawaqed F, Suoub M (2021) Validating 7-items overactive bladder symptom score (OABSS) through Arabic linguistic version. Sci Rep 11(1):661","journal-title":"Sci Rep"},{"issue":"6","key":"6249_CR18","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s11136-006-0041-9","volume":"15","author":"L Grilli","year":"2006","unstructured":"Grilli L et al (2006) Associations between a functional independence measure (WeeFIM) and the pediatric quality of life inventory (PedsQL4.0) in young children with physical disabilities. Qual Life Res 15(6):1023\u20131031","journal-title":"Qual Life Res"},{"issue":"2","key":"6249_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.urology.2006.02.042","volume":"68","author":"Y Homma","year":"2006","unstructured":"Homma Y et al (2006) Symptom assessment tool for overactive bladder syndrome: overactive bladder symptom score. Urology 68(2):318\u201323","journal-title":"Urology"},{"issue":"4","key":"6249_CR20","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.urology.2011.06.020","volume":"78","author":"M Gotoh","year":"2011","unstructured":"Gotoh M et al (2011) Responsiveness and minimal clinically important change in overactive bladder symptom score. Urology 78(4):768\u2013773","journal-title":"Urology"},{"issue":"8","key":"6249_CR21","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","volume":"39","author":"JW Varni","year":"2001","unstructured":"Varni JW, Seid M, Kurtin PS (2001) PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care 39(8):800\u2013812","journal-title":"Med Care"},{"issue":"4","key":"6249_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.4081\/aiua.2022.4.492","volume":"94","author":"R Bapir","year":"2022","unstructured":"Bapir R et al (2022) Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials. Arch Ital Urol Androl 94(4):492\u2013506","journal-title":"Arch Ital Urol Androl"},{"issue":"2","key":"6249_CR23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/nau.23351","volume":"37","author":"J Booth","year":"2018","unstructured":"Booth J et al (2018) The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review. Neurourol Urodyn 37(2):528\u2013541","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"6249_CR24","doi-asserted-by":"publisher","first-page":"101486","DOI":"10.1016\/j.rehab.2021.101486","volume":"65","author":"R Sonmez","year":"2022","unstructured":"Sonmez R, Yildiz N, Alkan H (2022) Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial. Ann Phys Rehabil Med 65(1):101486","journal-title":"Ann Phys Rehabil Med"},{"key":"6249_CR25","doi-asserted-by":"publisher","first-page":"175628722110414","DOI":"10.1177\/17562872211041470","volume":"13","author":"M Te Dorsthorst","year":"2021","unstructured":"Te Dorsthorst M et al (2021) Real-life patient experiences of TTNS in the treatment of overactive bladder syndrome. Ther Adv Urol 13:17562872211041470","journal-title":"Ther Adv Urol"},{"issue":"Suppl 4","key":"6249_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12911-023-02375-1","volume":"23","author":"X Zhang","year":"2024","unstructured":"Zhang X et al (2024) Evaluating MedDRA-to-ICD terminology mappings. BMC Med Inf Decis Mak 23(Suppl 4):299","journal-title":"BMC Med Inf Decis Mak"},{"issue":"5","key":"6249_CR27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/CCO.0000000000001056","volume":"36","author":"MF Fey","year":"2024","unstructured":"Fey MF et al (2024) Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trials. Curr Opin Oncol 36(5):418\u2013420","journal-title":"Curr Opin Oncol"},{"issue":"9","key":"6249_CR28","doi-asserted-by":"publisher","first-page":"e14342","DOI":"10.1111\/ijcp.14342","volume":"75","author":"O Alkis","year":"2021","unstructured":"Alkis O et al (2021) Comparison of transcutaneous tibial nerve stimulation (TTNS) protocols for women with refractory overactive bladder (OAB): A prospective randomised trial. Int J Clin Pract 75(9):e14342","journal-title":"Int J Clin Pract"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06249-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06249-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06249-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:50:09Z","timestamp":1772628609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06249-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6249"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06249-9","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and relevant institutional guidelines. The protocol was reviewed and approved by the Ethics Committee of Qilu Hospital, Shandong University (approval No.: KYLL-202502(YJ)-004; approval date: 2025-02-27). Written informed consent was obtained from the parents or legal guardians of all participants; age-appropriate assent was obtained from children aged\u2009\u2265\u20098 years, in line with institutional policy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"218"}}